Lawton Vincent Michael
Reporting owner on Forms 3, 4 and 5, CIK 2123870.
Lawton Vincent Michael reported on 1 issuer in 2 filings, the latest a Form 4/A filed 2026-11-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Addex Therapeutics Ltd. CIK 1574232 | director | 2 | 2026-11-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ADXN · Addex Therapeutics Ltd.Stock-option (Right to Buy), derivative | 2026-11-11 | A granted | +1,885,708 | $0 | 2,387,306 | Form 4/A |
| ADXN · Addex Therapeutics Ltd.Stock-option (Right to Buy), derivative, superseded by an amendment | 2026-11-11 | A granted | +942,854 | $0 | 1,444,452 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4/A 0001104659-26-128208 | Addex Therapeutics Ltd. | 2026-11-16 | ||
| Form 4 0001104659-26-127029 | Addex Therapeutics Ltd. | 2026-11-13 |